<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">


LSX World Congress formerly known as Biotech and Money Congress
etc.venues St Paul's
February 5-6, 2019
 

Meet our speakers

Amina Albeyatti

Amina Albeyatti

Head of Business Development
MyClinic.com
Sascha Alilovic, Partner, SHS

Sascha Alilovic

Partner
SHS
Sophie Baratte, CEO, Cellnovo

Sophie Baratte

CEO
Cellnovo
Assaf-Barnea

Assaf Barnea

CEO
Sanara Ventures
Alexander Belcredi, CEO, PhagoMed

Alexander Belcredi

CEO
PhagoMed
Alessio Beverina, Panakes partners

Alessio Beverina

Founder and Managing Partner
Panakès Partners
Hubert Birner, Managing Partner, TVM Capital

Hubert Birner

Managing Partner
TVM Capital Life Science
Michael Bloch, Counsel, Allen & Overy

Michael Bloch

Counsel
Allen & Overy
JASPER BOS

JASPER BOS

Vice President, Head of Healthcare Fund
M Ventures
John Bowis, International health policy

John Bowis

International Health Policy Advisor
Thomas Burt, Partner, Soffinova

Thomas Burt

Partner, Crossover Fund
Sofinnova
Amanda Cashin, Co-Founder, Illumina Accelerator

Amanda Cashin

Co-Founder
Illumina Accelerator
Pierre Chauvineau, VP, Rhythm Management, Boston Scientific

Pierre Chauvineau

VP, Rhythm Management
Boston Scientific
Maria Chatzou, CEO, Lifebit Biotech


Maria Chatzou

CEO
Lifebit Biotech

Alain Chevallier, Partner Life Sciences, Truffle Capital

Alain Chevallier

Partner, Life Sciences
Truffle Capital
Robert Chu, CEO & CTO, Embleema

Robert Chu

CEO & CTO
Embleema
CHRISTOPHER CLEARY, VP, Medtronic

Christopher Cleary

Vice President of Corporate Development
Medtronic
Katherine Cohen, Venture Partner, Panacea Venture

Katherine Cohen

Venture Partner
Panacea Venture
Sarah Cole

Sarah Cole

Partner
Takeda Ventures
Clive Cookson, Science Editor, Financial Times

Clive Cookson

Science Editor
Financial Times
Mick Cooper, Healthcare & Life Sciences Analyst, Trinity Delta

Mick Cooper

Healthcare & Life Sciences Analyst
Trinity Delta
Ian Crosbie, CEO, Sequana Medical

Ian Crosbie

CEO
Sequana Medical
Nissim Darvish, Senior Managing Director, Orbimed

Nissim Darvish

Senior Managing Director
Orbimed
John Dawson, CEO, Oxford Biomedica

John Dawson

CEO
Oxford Biomedica
Fiona de Hemptinne, Venture Partner, UCB Ventures

Fiona de Hemptinne

Venture Partner
UCB Ventures
Olivier Delporte, CEO, Miracor Medical

Olivier Delporte

CEO
Miracor Medical
Francesco-1

Francesco De Rubertis

Co-Founder and Partner
Medicxi
Emmanuel de Watteville, General Partner and Co-Founder, BlueOcean Ventures

Emmanuel de Watteville

General Partner and Co-Founder
BlueOcean Ventures
Dimitri Dimitriou, CEO, Immupharma

Dimitri Dimitriou

CEO
Immupharma
Helen Disney, Founder, Unblocked Events

Helen Disney

Founder
Unblocked
Matthew Dodds, Vice President, Strategic Planning, Livanova confirmed for London

Matthew Dodds

Vice President, Strategic Planning
Livanova
Lord Drayson, CEO, Sensyne

Lord Drayson

CEO
Sensyne Health
Johnston-Erwin

Johnston Erwin

VP Corporate Business Development
Eli Lilly
Miriam Frieden, Vice President R&D Innovation Sourcing, Novo Nordisk

Miriam Frieden

VP of Search & Evaluation
Novo Nordisk
Martin Frost, CEO, CMR Surgical

Martin Frost

CEO
CMR Surgical
Jochen Gann, Head of Global M&A, Boehringer

Jochen Gann

Head of Global M&A and Corporate Finance
Boehringer Ingelheim
Juan Garcia, Managing Partner, Bioseed Capital

Juan Garcia

Managing Partner
Bioseed Capital
Christian Glennie, Director - Equity Research, Healthcare, Stifel  -017690-edited

Christian Glennie

Director - Equity Research, Healthcare
Stifel
Jonathan Goldstein Boston SCientific

Jonathan Goldstein

Director, Corporate Research and Ventures
Boston Scientific
Jens Grueger

Jens Grueger

SVP Global Access
Roche
Shaun Grady, VP Global Business Development, AstraZeneca

Shaun Grady

VP Global Business Development
AstraZeneca
Mattias Häggblom, Portfolio Manager - Global Healthcare, Swedbank Robur

Mattias Häggblom

Portfolio Manager - Global Healthcare
Swedbank Robur
Tim Haines, Managing Partner, Abingworth

Tim Haines

Managing Partner
Abingworth
Mark Hahnel, Associate Founder, Genomes.io

Mark Hahnel

Associate Founder
Genomes.io
Deborah Harland

Deborah Harland

Partner
SR One
Zishan Haroon, General Partner, Julz

Zishan Haroon

General Partner
Julz & Co
John Hodgson

John Hodgson

Independent Consultant
Jens Holstein, CFO, Morphosys

Jens Holstein

CFO
Morphosys
Asaf Homossany Managing Director EMEA Nasdaq

Asaf Homossany

Managing Director - EMEA
Nasdaq
Thomas Holm Pedersen, CEO, NMD Pharma

Thomas Holm Pedersen

CEO
NMD Pharma
Andrew Hotchkiss, CEO, Immunocore

Andrew Hotchkiss

CEO
Immunocore
Jackie Hunter, Chief Executive, BenevolentBio

Jackie Hunter

Chief Executive
BenevolentBio
Anthony Joseph, CTO, Unite Genomics

Anthony Joseph

CTO
Unite Genomics
Christoph Kausch, Founding Partner & CEO, MTIP

Christoph Kausch

Founding Partner & CEO
MTIP
Yiannis Kiachopoulos, CEO, Causaly

Yiannis Kiachopoulos

CEO
Causaly
Sameer Kothari, CEO, Zilico

Sameer Kothari

CEO
Zilico
Lena Krzyzak, Investment Manager, High-Tech Gründerfonds. png

Lena Krzyzak

Investment Manager
High-Tech Gründerfonds
Lara Koole, Principal, Philips Health Technology Ventures

Lara Koole

Principal
Philips Health Technology Ventures
Dmitry Kuzmin, Managing Partner, 4BIO Capital Partners

Dmitry Kuzmin

Managing Partner
4BIO Capital Partners
Chandra Leo, Partner, HBM Partners

Chandra Leo

Partner
HBM Partners
Stephan Lensky, CBO, EpimAb

Stephan Lensky

CBO
EpimAb
Kit Latham, CEO, drfocused

Kit Latham

CEO
Drfocused
Trevor Leighton, Vice President, Market Access, Argenx

Trevor Leighton

Vice President, Market Access
Argenx
Oliver Litzka, Partner, Andera Partners

Oliver Litzka

Partner
Andera Partners
Carole Longson, Nice

Carole Longson

Former Director of NICE and CSO
ABPI
Thomas Lonngren, former Head of EMA and Senior Advisor, NDA Group

Thomas Lonngren

Former Head of EMA and Senior Advisor
NDA Group
Phil L'Huillier, MSD

Phil L'Huillier

Head of Business Development, Europe, European Innovation Hub
MSD
Tim Luker, Sr. Director, Emerging Technology & Innovation, BD, Eli Lilly

Tim Luker

Emerging Technology & Innovation, BD
Eli Lilly
Manish Marotkar, Head of Business Development, Siemens Healthineers Digital Ecosystem

Manish Marotkar

Head of Business Development
Siemens Healthineers Digital Ecosystem
John Milad, CEO, QuantaDT

John Milad

CEO
QuantaDT
Sean Marett, CBO & CCO, BioNTech

Sean Marett

CBO & CCO
BioNTech
Soren Moller

Søren Møller

Managing Partner
Novo Seeds
Angeli Möller, Head of IT Business Partnering Research, Bayer Business Services

Angeli Möller

Head of IT Business Partnering Research
Bayer Business Services
Piers Morgan, CFO, Verona Pharma

Piers Morgan

CFO
Verona Pharma
Savvas Neophytou,Partner & Head of Life Sciences, Deepbridge Capital

Savvas Neophytou

Partner & Head of Life Sciences
Deepbridge Capital
Daniel O’Mahony, Partner, Seroba Life Sciences

Daniel O’Mahony

Partner
Seroba Life Sciences
Geraldine O’Keeffe, Partner, LSP

Geraldine O’Keeffe

Partner
LSP
Natalie Pankova, COO, Project Shivom

Natalie Pankova

COO
Project Shivom
Alex Pasteur, Partner, F-Prime Capital Partners

Alex Pasteur

Partner
F-Prime Capital Partners
James Peyer, Managing Partner, Apollo Ventures

James Peyer

Managing Partner
Apollo Ventures
Martin Pfister, Senior Investment Manager, HTGF

Martin Pfister

Senior Investment Manager
HTGF
David Pinniger, CFA, Polar Capital Partners

David Pinniger

Fund Manager - Biotechnology
Polar Capital
John Power, CEO & Managing Director, Aerogen Ltd

John Power

CEO & Managing Director
Aerogen Ltd
Pablo Prieto, CTO, Lifebit

Pablo Prieto

CTO
Lifebit
Aditya Puri, Partner, Investments, Xeraya Capital

Aditya Puri

Partner - Investments
Xeraya Capital
Conrad Rasmus, Co-Founder, Protembis

Conrad Rasmus

Co-Founder
Protembis
Dan Rose, CEO, Limflow

Dan Rose

CEO
Limflow
Claudio Rumazza, Partner, Innogest Capital

Claudio Rumazza

Partner
Innogest Capital
Josep Sanfeliu, Managing Partner, Asabys Partners

Josep Sanfeliu

Managing Partner
Asabys Partners
Dominic Schmidt, Partner, Syncona

Dominic Schmidt

Partner
Syncona Investment Management
Matthew Scholz, CEO, Oisin

Matthew Scholz

CEO
Oisin Biotechnologies
Nerida Scott, New Ventures And Transactions, J&J-1

Nerida Scott

New Ventures And Transactions
J&J
Graziano Seghezzi, Managing Partner, Sofinnova Partners

Graziano Seghezzi

Managing Partner
Sofinnova Partners
Johan Sellström, Co-Founder, CareChain

Johan Sellström

Co-Founder
CareChain
Nigel_Sheail_Global_Head_of_M&A_and_BD&L_Novartis

Nigel Sheail

Head BD&L
Novartis
Harpreet Singh, CEO, Immatics

Harpreet Singh

CEO
Immatics
Yochi Slonim, CEO, Anima Biotech

Yochi Slonim

CEO
Anima Biotech
Bobby Soni, Partner, Life Science

Bobby Soni

Partner - Life Science Investments
IP Group
Nikolaj Sorenson, CEO, Orexo

Nikolaj Sorenson

CEO
Orexo
Ivo Staijen, Portfolio Manager, HBM Partners

Ivo Staijen

Portfolio Manager
HBM Partners
Casey Swerner, Analyst, DN Capital

Casey Swerner

Analyst
DN Capital
Chas Taylor

Chas Taylor

CEO
Veryan
Anton Ussi, Director Operations & Finance, EATRIS

Anton Ussi

Director Operations & Finance
EATRIS
Laurent Vandebrouck, CEO Chronolife and CEO Connected Health Development

Laurent Vandebrouck

CEO
Chronolife and Connected Health Development
Edward Van Wezel, Managing Partner, Biogeneration Ventures

Edward Van Wezel

Managing Partner
BioGeneration Ventures
Gary Waanders, Managing Director - UK Healthcare Research, Bryan, Garnier & Co.     png

Gary Waanders

Managing Director - UK Healthcare Research
Bryan, Garnier & Co.
Susana Waesch, VP Quality Management and Regulatory Affairs, Yposmed

Susana Waesch

VP Quality Management & Regulatory Affairs
Ypsomed AG
Franz Warner Haas, COO, CureVac

Franz Warner Haas

COO
CureVac
Boris Zaitra, Global Head of M&A, Roche

Boris Zaitra

Global Head of M&A
Roche
ENQUIRE HERE

Never miss an update

Sign up to event updates to hear about new speakers, promotions, conference news and networking events.